Literature DB >> 7468472

Prognostic importance of anginal symptoms in angiographically defined coronary artery disease.

P F Cohn, P Harris, W H Barry, R A Rosati, P Rosenbaum, C Waternaux.   

Abstract

To evaluate the prognostic importance of anginal symptoms, 44 patients with angiographically defined coronary artery disease and no anginal symptoms at time of cardiac catheterization were selected from the Duke Harvard Collaborative Data Bank. They were "matched" with 127 symptomatic patients in the Data Bank who had similar coronary anatomy and ventricular function. Follow-up data indicated that the patients without anginal symptoms had a significantly better prognosis over a 7 year period than did those with symptoms: Annual mortality in the asymptomatic group was 2.7 percent compared with 5.4 percent in the group with angina (P 0.05). Although the patient population was a highly selective one and the matching categories were relatively broad, these results suggest that the presence of anginal symptoms may be an important independent correlate of prognosis in patients with coronary artery disease. The absence of angina did not preclude the presence of multivessel disease and did not necessarily imply a benign prognosis, because the yearly mortality rate was nearly 5 percent in the subgroup of asymptomatic patients with three vessel disease.

Entities:  

Mesh:

Year:  1981        PMID: 7468472     DOI: 10.1016/0002-9149(81)90391-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  8 in total

Review 1.  The practical implications of the coronary artery surgery trials.

Authors:  D G Julian
Journal:  Br Heart J       Date:  1985-10

2.  Clinical and Economic Implications of Inconclusive Noninvasive Test Results in Stable Patients With Suspected Coronary Artery Disease: Insights From the PROMISE Trial.

Authors:  Akash Goyal; Neha Pagidipati; C Larry Hill; Brooke Alhanti; James E Udelson; Michael H Picard; Patricia A Pellikka; Udo Hoffmann; Daniel B Mark; Pamela S Douglas
Journal:  Circ Cardiovasc Imaging       Date:  2020-04-09       Impact factor: 7.792

Review 3.  The combination of antianginal drugs: effects and indications.

Authors:  P R Lichtlen
Journal:  Cardiovasc Drugs Ther       Date:  1988-05       Impact factor: 3.727

4.  Occurrence of symptoms and depressive mood among working-aged coronary heart disease patients.

Authors:  Markku P T Sumanen; Sakari B Suominen; Markku J Koskenvuo; Lauri H Sillanmäki; Kari J Mattila
Journal:  Health Qual Life Outcomes       Date:  2004-11-08       Impact factor: 3.186

5.  Comparative effectiveness of Di'ao Xin Xue Kang capsule and Compound Danshen tablet in patients with symptomatic chronic stable angina.

Authors:  Yanan Yu; Siyuan Hu; Guoxin Li; Jie Xue; Zhuoming Li; Xiangling Liu; Xiyan Yang; Bo Dong; Donghai Wang; Xiaofeng Wang; Shurong Liu; Jun Liu; Bingwei Chen; Liying Wang; Songshan Liu; Qiguang Chen; Chunti Shen; Zhong Wang; Yongyan Wang
Journal:  Sci Rep       Date:  2014-11-14       Impact factor: 4.379

6.  Prevalence of Angina Among Primary Care Patients With Coronary Artery Disease.

Authors:  Daniel M Blumenthal; Sidney E Howard; Jennifer Searl Como; Sandra M O'Keefe; Steven J Atlas; Daniel M Horn; Neil W Wagle; Jason H Wasfy; Robert W Yeh; Joshua P Metlay
Journal:  JAMA Netw Open       Date:  2021-06-01

7.  Angina and Future Cardiovascular Events in Stable Patients With Coronary Artery Disease: Insights From the Reduction of Atherothrombosis for Continued Health (REACH) Registry.

Authors:  Alon Eisen; Deepak L Bhatt; P Gabriel Steg; Kim A Eagle; Shinya Goto; Jianping Guo; Sidney C Smith; E Magnus Ohman; Benjamin M Scirica
Journal:  J Am Heart Assoc       Date:  2016-09-28       Impact factor: 5.501

8.  International Observational Analysis of Evolution and Outcomes of Chronic Stable Angina: The Multinational CLARIFY Study.

Authors:  Jules Mesnier; Gregory Ducrocq; Nicolas Danchin; Roberto Ferrari; Ian Ford; Jean-Claude Tardif; Michal Tendera; Kim M Fox; Philippe Gabriel Steg
Journal:  Circulation       Date:  2021-07-15       Impact factor: 29.690

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.